Guggenheim Capital LLC Bio Rad Laboratories, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 1,630 shares of BIO stock, worth $556,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,630
Previous 2,697 39.56%
Holding current value
$556,661
Previous $736,000 25.95%
% of portfolio
0.0%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$263.97 - $344.64 $281,655 - $367,730
-1,067 Reduced 39.56%
1,630 $545,000
Q2 2024

Aug 14, 2024
SELL
$268.26 - $339.48 $15,827 - $20,029
-59 Reduced 2.14%
2,697 $736,000
Q1 2024

May 14, 2024
SELL
$304.11 - $351.99 $143,844 - $166,491
-473 Reduced 14.65%
2,756 $953,000
Q4 2023

Feb 14, 2024
BUY
$269.37 - $365.04 $388,700 - $526,752
1,443 Added 80.8%
3,229 $1.04 Million
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $7,005 - $8,452
-20 Reduced 1.11%
1,786 $640,000
Q2 2023

Aug 11, 2023
SELL
$359.49 - $486.4 $46,014 - $62,259
-128 Reduced 6.62%
1,806 $684,000
Q1 2023

May 10, 2023
BUY
$418.69 - $503.0 $242,840 - $291,740
580 Added 42.84%
1,934 $926,000
Q4 2022

Feb 14, 2023
SELL
$351.71 - $456.01 $83,706 - $108,530
-238 Reduced 14.95%
1,354 $569,000
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $103,147 - $140,815
250 Added 18.63%
1,592 $664,000
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $1.71 Million - $2.21 Million
-3,695 Reduced 73.36%
1,342 $664,000
Q1 2022

May 16, 2022
SELL
$524.57 - $735.42 $809,936 - $1.14 Million
-1,544 Reduced 23.46%
5,037 $2.84 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $4.58 Million - $5.13 Million
-6,459 Reduced 49.53%
6,581 $4.97 Million
Q3 2021

Nov 15, 2021
SELL
$657.71 - $825.77 $2.19 Million - $2.75 Million
-3,336 Reduced 20.37%
13,040 $9.73 Million
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $2.96 Million - $3.33 Million
5,125 Added 45.55%
16,376 $10.6 Million
Q1 2021

May 13, 2021
SELL
$547.01 - $662.35 $19,145 - $23,182
-35 Reduced 0.31%
11,251 $6.43 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $4.51 Million - $5.68 Million
8,830 Added 359.53%
11,286 $6.58 Million
Q3 2020

Nov 13, 2020
SELL
$454.43 - $535.6 $353,546 - $416,696
-778 Reduced 24.06%
2,456 $1.27 Million
Q2 2020

Aug 14, 2020
BUY
$334.87 - $493.06 $825,454 - $1.22 Million
2,465 Added 320.55%
3,234 $1.46 Million
Q1 2020

Jun 02, 2020
SELL
$320.01 - $409.07 $370,251 - $473,293
-1,157 Reduced 60.07%
769 $270,000
Q4 2019

Feb 14, 2020
SELL
$319.73 - $374.2 $4.39 Million - $5.14 Million
-13,736 Reduced 87.7%
1,926 $713,000
Q3 2019

Nov 14, 2019
BUY
$304.55 - $345.24 $1.9 Million - $2.15 Million
6,230 Added 66.05%
15,662 $5.21 Million
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $48,491 - $52,827
169 Added 1.82%
9,432 $2.95 Million
Q1 2019

May 15, 2019
SELL
$224.3 - $317.41 $281,047 - $397,714
-1,253 Reduced 11.92%
9,263 $2.83 Million
Q4 2018

Feb 14, 2019
SELL
$220.1 - $309.0 $2.67 Million - $3.75 Million
-12,129 Reduced 53.56%
10,516 $2.44 Million
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $1.03 Million - $1.16 Million
3,554 Added 18.62%
22,645 $7.09 Million
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $4.12 Million - $5.13 Million
-16,889 Reduced 46.94%
19,091 $5.51 Million
Q1 2018

May 15, 2018
SELL
$233.97 - $274.11 $233,736 - $273,835
-999 Reduced 2.7%
35,980 $9 Million
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $1.79 Million - $2.23 Million
8,236 Added 28.65%
36,979 $8.83 Million
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $6.1 Million - $6.96 Million
28,743
28,743 $6.39 Million

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email